Literature DB >> 24412517

Ocular toxoplasmosis past, present and new aspects of an old disease.

M Maenz1, D Schlüter2, O Liesenfeld3, G Schares4, U Gross5, U Pleyer6.   

Abstract

Ocular toxoplasmosis (OT) is considered the most frequent form of infectious posterior uveitis and is caused by the protozoan parasite Toxoplasma gondii. The resulting vision loss frequently incapacitates patients and places a considerable socio-economic burden on societies in particular in developing countries. Although, toxoplasmic retinochoroiditis is a world-wide phenomenon stark regional differences with regard to prevalence and presumably route of infection exist. This review will discuss our current clinical understanding of OT including typical and atypical manifestations, patient characteristics which influence the course of disease and treatment options. Even though, congenital and acquired OT are not regarded as separate entities, certain differences exist, which will be assessed and evaluated in detail. A strong focus is laid on the disease causing parasite T. gondii, since solving the mystery of OT aetiology and the development of improved therapies will not be possibly with clinical science alone, but rather requires a precise understanding of parasitological and immunological pathomechanisms. Additionally, the biology and genetics of T. gondii form the foundation for novel and sophisticated diagnostic methods. Scientific advances in the recent years have shed some light on the different role of T. gondii strains with regard to OT manifestation and severity of disease. Genetic and environmental factors influencing OT will be presented and commonalities between OT and toxoplasmic encephalitis will be briefly discussed. Furthermore, the laboratory tools to study OT are crucial in our understanding of OT. In vivo and in vitro experimental approaches will be summarised and evaluated extensively. Finally, a brief outlook is given in which direction OT research should be headed in the future.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ocular toxoplasmosis; Retinochoroiditis; Toxoplasma gondii; Uveitis

Mesh:

Substances:

Year:  2014        PMID: 24412517     DOI: 10.1016/j.preteyeres.2013.12.005

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  59 in total

1.  Investigation of tissue cysts in the retina in a mouse model of ocular toxoplasmosis: distribution and interaction with glial cells.

Authors:  Hyun Beom Song; Bong-Kwang Jung; Jin Hyoung Kim; Young-Ha Lee; Min-Ho Choi; Jeong Hun Kim
Journal:  Parasitol Res       Date:  2018-06-02       Impact factor: 2.289

Review 2.  The molecular biology and immune control of chronic Toxoplasma gondii infection.

Authors:  Xiao-Yu Zhao; Sarah E Ewald
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 3.  Toxoplasmosis in Germany.

Authors:  Uwe Pleyer; Uwe Gross; Dirk Schlüter; Henrik Wilking; Frank Seeber
Journal:  Dtsch Arztebl Int       Date:  2019-06-21       Impact factor: 5.594

4.  Lack of association between Toxoplasma gondii infection and occupational exposure to animals.

Authors:  Cosme Alvarado-Esquivel; Sandy Janet Pacheco-Vega; Jesús Hernández-Tinoco; Diana Elizabeth Saldaña-Simental; Luis Francisco Sánchez-Anguiano; Misael Salcedo-Jáquez; Agar Ramos-Nevárez; Oliver Liesenfeld; José Ángel Márquez-Conde; Sandra Margarita Cerrillo-Soto; Lucio Martínez-Ramírez; Carlos Alberto Guido-Arreola
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-12-16

Review 5.  The role of sex in uveitis and ocular inflammation.

Authors:  Ian Y L Yeung; Nicholas A Popp; Chi-Chao Chan
Journal:  Int Ophthalmol Clin       Date:  2015

6.  Genetic Polymorphisms in Cytokine Genes in Colombian Patients with Ocular Toxoplasmosis.

Authors:  C A Naranjo-Galvis; A de-la-Torre; L E Mantilla-Muriel; L Beltrán-Angarita; X Elcoroaristizabal-Martín; R McLeod; N Alliey-Rodriguez; I J Begeman; C López de Mesa; J E Gómez-Marín; J C Sepúlveda-Arias
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

7.  Toxoplasma infection in patients with myocardial infarction.

Authors:  Omid Gohari; Abdolhossen Dalimi; Majid Pirestani
Journal:  Wien Klin Wochenschr       Date:  2020-06-05       Impact factor: 1.704

8.  IL-33/ST2 involves the immunopathology of ocular toxoplasmosis in murine model.

Authors:  Xinxin Tong; Fangli Lu
Journal:  Parasitol Res       Date:  2015-02-20       Impact factor: 2.289

9.  Ocular safety of Intravitreal Clindamycin Hydrochloride Released by PLGA Implants.

Authors:  Gabriella M Fernandes-Cunha; Silvia Ligório Fialho; Gisele Rodrigues da Silva; Armando Silva-Cunha; Min Zhao; Francine Behar-Cohen
Journal:  Pharm Res       Date:  2017-02-21       Impact factor: 4.200

10.  Acute Management of Optic Neuritis: An Evolving Paradigm.

Authors:  Lindsay Horton; Jeffrey L Bennett
Journal:  J Neuroophthalmol       Date:  2018-09       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.